Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
2014 · Nature Communications · 970 citations
https://doi.org/10.1038/ncomms6241
L
Lixia Diao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
606
Papers
23.6K
Citations
71
h-index
149
i10-index
Lixia Diao is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & RNA modifications and cancer. The author has an h-index of 71, co-authored 516 publications.
ORCID: 0000-0001-6995-4492Papers by this author
worksPatterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
2021 · Cancer Cell · 886 citations
https://doi.org/10.1016/j.ccell.2020.12.014
Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
2015 · Cancer Discovery · 883 citations
https://doi.org/10.1158/2159-8290.cd-14-1236
Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer
2019 · Cancer Discovery · 841 citations
https://doi.org/10.1158/2159-8290.cd-18-1020
A pan-cancer proteomic perspective on The Cancer Genome Atlas
2014 · Nature Communications · 624 citations
https://doi.org/10.1038/ncomms4887
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
2020 · Nature Communications · 429 citations
https://doi.org/10.1038/s41467-020-18298-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat